Supplementary figure 1.docx (30.58 kB)
Download fileEfficacy and safety of nivolumab for advanced/recurrent non-small-cell lung cancer: an up-to-date meta-analysis of large-scale phase III randomized controlled trials Supplementary figure 1
figure
posted on 2022-11-23, 14:27 authored by Hong Zhang, Limin Zhang, Keling Chen, Guo ChenEfficacy and safety of nivolumab for advanced/recurrent non-small-cell lung cancer: an up-to-date meta-analysis of large-scale phase III randomized controlled trials Supplementary figure 1
